Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

BUY
$82.56 - $93.49 $550,592 - $623,484
6,669 New
6,669 $597,000
Q3 2021

Oct 18, 2021

SELL
$57.6 - $70.59 $222,163 - $272,265
-3,857 Closed
0 $0
Q2 2021

Jul 30, 2021

BUY
$51.81 - $118.56 $16,838 - $38,532
325 Added 9.2%
3,857 $257,000
Q1 2021

Apr 20, 2021

SELL
$111.01 - $139.48 $49,510 - $62,208
-446 Reduced 11.21%
3,532 $392,000
Q4 2020

Jan 19, 2021

BUY
$88.75 - $119.95 $15,975 - $21,591
180 Added 4.74%
3,978 $472,000
Q3 2020

Oct 30, 2020

BUY
$75.65 - $93.58 $66,042 - $81,695
873 Added 29.85%
3,798 $331,000
Q2 2020

Jul 15, 2020

BUY
$84.96 - $118.91 $248,507 - $347,811
2,925 New
2,925 $262,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.21B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.